Editas Medicine receives approval for first-in-human clinical trial of EDIT-401 for hyperlipidemia

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-08T16:40:15Z
Category: business
Source: SEC.gov (Form 8-K filing)

Editas Medicine, Inc. announced that it has received approval to initiate a first-in-human clinical trial for EDIT-401. The trial will evaluate EDIT-401 in patients with hyperlipidemia.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai